AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21187622 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.23% APF gel iontophoresis
Number of subjects: 15
Study 21187622 — intervention group
Group type: COMPARATOR
Intervention: Aqueous solution of hydroxyl‐ethyl‐methacrylate and glutaraldehyde
Number of subjects: 15
Study 17996780 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic activities that mimic activities of daily living (ADL), 1 session per day for 3 weeks
Number of subjects: 36
Study 17996780 — intervention group
Group type: COMPARATOR
Intervention: Standard therapeutic exercises (passive, active assistive, and active range of motion and strengthening exercises), 2 sessions per day for 3 weeks
Number of subjects: 36
Study 14700505 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan
Number of subjects: 97
Study 14700505 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 97
Study 11782992 — intervention group
Group type: EXPERIMENTAL
Intervention: Median nerve stimulation for 2 hours
Number of subjects: 0
Study 9684120 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose branched chain amino acid-enriched solution (additional amount immediately after operation up until postoperative day 7)
Number of subjects: 8
Study 9684120 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose branched chain amino acid-enriched solution
Number of subjects: 8
Study 9684120 — intervention group
Group type: COMPARATOR
Intervention: Conventional postoperative hyperalimentation (control group)
Number of subjects: 8
Study 7601179 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimesulide (100 mg bid)
Number of subjects: 205
Study 7601179 — intervention group
Group type: COMPARATOR
Intervention: Naproxen sodium (550 mg bid)
Number of subjects: 205
Study 3387419 — intervention group
Group type: EXPERIMENTAL
Intervention: Titrimetric method
Number of subjects: 128
Study 3387419 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectrophotometric method
Number of subjects: 128
Study 29080920 — intervention group
Group type: EXPERIMENTAL
Intervention: NEPA (netupitant-palonosetron)
Number of subjects: 0
Study 29080920 — intervention group
Group type: COMPARATOR
Intervention: Palonosetron
Number of subjects: 0
Study 28041917 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Remediation (CR) combined with Vocational Rehabilitation (VR)
Number of subjects: 131
Study 28041917 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT) combined with Vocational Rehabilitation (VR)
Number of subjects: 131
Study 25809235 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral stress management (CBSM)
Number of subjects: 100
Study 25809235 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducational control group
Number of subjects: 100
Study 22923150 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH antagonist protocol with luteal estradiol pre-treatment (daily oral Estradiol Valerate 4 mg from the 21st day until the first day of the next cycle)
Number of subjects: 116
Study 22923150 — intervention group
Group type: COMPARATOR
Intervention: Micro dose GnRH agonist protocol
Number of subjects: 116
Study 21911721 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyurea (HU)
Number of subjects: 285
Study 21911721 — intervention group
Group type: COMPARATOR
Intervention: Pipobroman
Number of subjects: 285
Study 19018196 — intervention group
Group type: EXPERIMENTAL
Intervention: Repositioning every 4 hours with an appropriate pressure redistribution surface
Number of subjects: 0
Study 19018196 — intervention group
Group type: COMPARATOR
Intervention: Repositioning every 2 hours
Number of subjects: 0
Study 19018196 — intervention group
Group type: COMPARATOR
Intervention: 30 degrees lateral position
Number of subjects: 0
Study 19018196 — intervention group
Group type: COMPARATOR
Intervention: 90 degrees lateral position
Number of subjects: 0
Study 19018196 — intervention group
Group type: COMPARATOR
Intervention: Semi-Fowler's position
Number of subjects: 0
Study 16618976 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training program (30-60 min/day, 60-70% HR-reserve, 200-400 kcal, 4-5 days/week)
Number of subjects: 96
Study 16618976 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 96
Study 14695934 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg coenzyme Q10
Number of subjects: 99
Study 14695934 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg coenzyme Q10
Number of subjects: 99
Study 14695934 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 10955324 — intervention group
Group type: EXPERIMENTAL
Intervention: DR4/1 peptide injections every 6 weeks
Number of subjects: 53
Study 10955324 — intervention group
Group type: EXPERIMENTAL
Intervention: DR4/1 peptide injections every 8 weeks
Number of subjects: 53
Study 10955324 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 53
Study 8617186 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 g lactitol in milk chocolate
Number of subjects: 59
Study 8617186 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 g isomalt in milk chocolate
Number of subjects: 59
Study 8617186 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g isomalt in milk chocolate
Number of subjects: 59
Study 8617186 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 g maltitol in milk chocolate
Number of subjects: 59
Study 8617186 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g maltitol in milk chocolate
Number of subjects: 59
Study 8339411 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg flosequinan once daily
Number of subjects: 322
Study 8339411 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg flosequinan twice daily
Number of subjects: 322
Study 8339411 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 322
Study 3722034 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefamandole
Number of subjects: 60
Study 3722034 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime
Number of subjects: 60
Study 3722034 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephradine
Number of subjects: 60
Study 29723578 — intervention group
Group type: EXPERIMENTAL
Intervention: Transversus Abdominis Plane (TAP) Block
Number of subjects: 83
Study 29723578 — intervention group
Group type: COMPARATOR
Intervention: Epidural
Number of subjects: 83
Study 26805418 — intervention group
Group type: EXPERIMENTAL
Intervention: 4‐t‐butylcyclohexanol (Eucerin UltraSensitive Soothing Care Dry Skin)
Number of subjects: 31
Study 26805418 — intervention group
Group type: COMPARATOR
Intervention: Acetyl dipeptide‐1 cetyl ester (La Roche‐Posay Toleriane Ultra Intense Soothing Care)
Number of subjects: 31
Study 26597128 — intervention group
Group type: COMPARATOR
Intervention: Continued standard nutritional support
Number of subjects: 339
Study 26597128 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocolised caloric restriction
Number of subjects: 339
Study 24278923 — intervention group
Group type: EXPERIMENTAL
Intervention: Zirconium oxide healing caps
Number of subjects: 5
Study 24278923 — intervention group
Group type: COMPARATOR
Intervention: Titanium healing caps
Number of subjects: 5
Study 21231989 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical microemulsion
Number of subjects: 0
Study 21231989 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline
Number of subjects: 0
Study 18336952 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically modified food products
Number of subjects: 0
Study 18336952 — intervention group
Group type: EXPERIMENTAL
Intervention: Processed food products
Number of subjects: 0
Study 18336952 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-processed genetically modified products
Number of subjects: 0
Study 18336952 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-genetically modified processed products
Number of subjects: 0
Study 16492607 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg x kg(‐1) body mass)
Number of subjects: 8
Study 16492607 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 16492607 — intervention group
Group type: COMPARATOR
Intervention: No supplement
Number of subjects: 8
Study 12943431 — intervention group
Group type: EXPERIMENTAL
Intervention: Cleft lip and palate patients
Number of subjects: 18
Study 12943431 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 18
Study 11044499 — intervention group
Group type: EXPERIMENTAL
Intervention: Vesta system for endometrial ablation
Number of subjects: 234
Study 11044499 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment (rollerball or resection)
Number of subjects: 234
Study 9175147 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin (TNG)
Number of subjects: 0
Study 9175147 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem hydrochloride (DH)
Number of subjects: 0
Study 9175147 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethaphan camsilate (TC)
Number of subjects: 0
Study 8465780 — intervention group
Group type: EXPERIMENTAL
Intervention: Bezafibrate 400 mg daily
Number of subjects: 3000
Study 8465780 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3000
Study 3008669 — intervention group
Group type: EXPERIMENTAL
Intervention: OK‐432
Number of subjects: 178
Study 3008669 — intervention group
Group type: EXPERIMENTAL
Intervention: PSK
Number of subjects: 178
Study 3008669 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 178
Study 3008669 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (VCR, MMC, MTX)
Number of subjects: 178
Study 31174600 — intervention group
Group type: EXPERIMENTAL
Intervention: BuMA Supreme stent
Number of subjects: 80
Study 31174600 — intervention group
Group type: COMPARATOR
Intervention: XIENCE stent
Number of subjects: 80
Study 30021528 — intervention group
Group type: EXPERIMENTAL
Intervention: Frailty
Number of subjects: 3904
Study 30021528 — intervention group
Group type: EXPERIMENTAL
Intervention: >8 diagnoses
Number of subjects: 3904
Study 30021528 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI ≥30
Number of subjects: 3904
Study 30021528 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower SF-12 physical health composite score
Number of subjects: 3904
Study 30021528 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower SF-12 mental health composite score
Number of subjects: 3904
Study 30021528 — intervention group
Group type: EXPERIMENTAL
Intervention: Age ≥85 years
Number of subjects: 3904
Study 30021528 — intervention group
Group type: EXPERIMENTAL
Intervention: Being recruited in the UK
Number of subjects: 3904
Study 30021528 — intervention group
Group type: EXPERIMENTAL
Intervention: Being recruited in Germany 2/Witten
Number of subjects: 3904
Study 26538364 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-6
Number of subjects: 330
Study 26538364 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-10
Number of subjects: 330
Study 26538364 — intervention group
Group type: COMPARATOR
Intervention: TNF-α
Number of subjects: 330
Study 26538364 — intervention group
Group type: COMPARATOR
Intervention: CRP
Number of subjects: 330
Study 24863250 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid human milk fortifier (LHMF; provided additional 12mg docosahexaenoic acid (DHA), 20mg arachidonic acid (ARA)/100mL human milk)
Number of subjects: 150
Study 24863250 — intervention group
Group type: COMPARATOR
Intervention: Control human milk fortifier (HMF; providing no DHA or ARA)
Number of subjects: 150
Study 22453866 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan
Number of subjects: 8
Study 20443731 — intervention group
Group type: EXPERIMENTAL
Intervention: Q‐TER(®), 160 mg, once a day for 30 days
Number of subjects: 60
Study 20443731 — intervention group
Group type: COMPARATOR
Intervention: Vitamin E, 50 mg, once a day for 30 days
Number of subjects: 60
Study 20443731 — intervention group
Group type: COMPARATOR
Intervention: Placebo, once a day for 30 days
Number of subjects: 60
Study 19057624 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 16099630 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fat diet with omega-3 fatty acids (Fish Oil group)
Number of subjects: 31
Study 16099630 — intervention group
Group type: COMPARATOR
Intervention: Olive Oil diet (Olive Oil group)
Number of subjects: 31
Study 12423514 — intervention group
Group type: EXPERIMENTAL
Intervention: Photochemically treated FFP (with amotosalen and UVA light)
Number of subjects: 0
Study 12423514 — intervention group
Group type: COMPARATOR
Intervention: Standard FFP
Number of subjects: 0
Study 10509550 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine-metoprolol combination tablet (Logimax), 5/50 mg daily
Number of subjects: 321
Study 10509550 — intervention group
Group type: COMPARATOR
Intervention: Enalapril, 10 mg daily
Number of subjects: 321
Study 10509550 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 321
Study 10509550 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine-metoprolol combination tablet (Logimax)
Number of subjects: 321
Study 10509550 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 321
Study 8608476 — intervention group
Group type: EXPERIMENTAL
Intervention: Edmondson's Grades I + II
Number of subjects: 124
Study 8608476 — intervention group
Group type: COMPARATOR
Intervention: Edmondson's Grades III + IV
Number of subjects: 124
Study 8608476 — intervention group
Group type: EXPERIMENTAL
Intervention: Histologic grade
Number of subjects: 124
Study 8608476 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitotic index
Number of subjects: 124
Study 8608476 — intervention group
Group type: EXPERIMENTAL
Intervention: Edmondson's grading
Number of subjects: 124
Study 1563195 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperature measurement (AUC calculated from rectal temperature measurements one to four times a day)
Number of subjects: 191
Study 4077506 — intervention group
Group type: EXPERIMENTAL
Intervention: Group treatment with the duo formula (12 sessions over 3 months)
Number of subjects: 0
Study 4077506 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 31484661 — intervention group
Group type: EXPERIMENTAL
Intervention: Cellphone-based daily medication and weekly pill refilling reminders in addition to usual care
Number of subjects: 0
Study 31484661 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 30134283 — intervention group
Group type: COMPARATOR
Intervention: 0.6 mg/kg oxycodone alone (Group C)
Number of subjects: 99
Study 30134283 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 mg/kg oxycodone + 2.4 μg/kg DEX (Group D1)
Number of subjects: 99
Study 30134283 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 mg/kg oxycodone + 4.8 μg/kg DEX (Group D2)
Number of subjects: 99
Study 26659543 — intervention group
Group type: EXPERIMENTAL
Intervention: GHB 25 mg kg(‐1)
Number of subjects: 32
Study 26659543 — intervention group
Group type: EXPERIMENTAL
Intervention: GHB 35 mg kg(‐1)
Number of subjects: 32
Study 26659543 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 24615681 — intervention group
Group type: EXPERIMENTAL
Intervention: ONO-5334 sustained release tablet (SRT)
Number of subjects: 0
Study 24615681 — intervention group
Group type: EXPERIMENTAL
Intervention: ONO-5334 immediate release tablet (IRT)
Number of subjects: 0
Study 23047652 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomegranate juice
Number of subjects: 0
Study 23047652 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomegranate extract (1-g capsule)
Number of subjects: 0
Study 23047652 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole (positive control)
Number of subjects: 0
Study 23047652 — intervention group
Group type: COMPARATOR
Intervention: Low-polyphenol placebo control beverage
Number of subjects: 0
Study 20477733 — intervention group
Group type: EXPERIMENTAL
Intervention: Three additional asthma education sessions with a trained IHCW
Number of subjects: 88
Study 20477733 — intervention group
Group type: COMPARATOR
Intervention: No additional asthma education
Number of subjects: 88
Study 17957793 — intervention group
Group type: EXPERIMENTAL
Intervention: Flutamide 250 mg/day
Number of subjects: 172
Study 17957793 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 172
Study 16273966 — intervention group
Group type: EXPERIMENTAL
Intervention: Raised bricklaying devices
Number of subjects: 202
Study 12117482 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumatic abdomino‐diaphragmatic belt respiratory assistance
Number of subjects: 7
Study 12117482 — intervention group
Group type: COMPARATOR
Intervention: Quiet breathing without the belt
Number of subjects: 7
Study 10049955 — intervention group
Group type: EXPERIMENTAL
Intervention: Lead dust intervention composed of maternal education and biweekly assistance with household cleaning
Number of subjects: 113
Study 10049955 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 113
Study 10049955 — intervention group
Group type: EXPERIMENTAL
Intervention: Lead dust intervention with regular cleaning (20 or more times throughout the year)
Number of subjects: 113
Study 10049955 — intervention group
Group type: EXPERIMENTAL
Intervention: Lead dust intervention
Number of subjects: 113
Study 7573878 — intervention group
Group type: EXPERIMENTAL
Intervention: New technique of insertion with anterior displacement of the mandible
Number of subjects: 20
Study 7573878 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique of insertion
Number of subjects: 20
Study 1889697 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracycline therapy
Number of subjects: 16
Study 1889697 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 16
Study 1889697 — intervention group
Group type: COMPARATOR
Intervention: Atrophic gastritis subjects
Number of subjects: 16
Study 6211987 — intervention group
Group type: EXPERIMENTAL
Intervention: Minilaparotomy
Number of subjects: 1610
Study 6211987 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopy
Number of subjects: 1610
Study 31655214 — intervention group
Group type: EXPERIMENTAL
Intervention: Toxigenic C. difficile isolates
Number of subjects: 331
Study 31655214 — intervention group
Group type: EXPERIMENTAL
Intervention: C. difficile strains producing binary toxin (CDT)
Number of subjects: 331
Study 31655214 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifaximin
Number of subjects: 331
Study 31655214 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin
Number of subjects: 331
Study 31655214 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotetan
Number of subjects: 331
Study 31655214 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin
Number of subjects: 331
Study 31655214 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipenem
Number of subjects: 331
Study 31655214 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloramphenicol
Number of subjects: 331
Study 31655214 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracycline
Number of subjects: 331
Study 31655214 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Number of subjects: 331
Study 31655214 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance genes
Number of subjects: 331
Study 31655214 — intervention group
Group type: EXPERIMENTAL
Intervention: RT018, 002, 017 and 369
Number of subjects: 331
Study 29861448 — intervention group
Group type: EXPERIMENTAL
Intervention: MAG-DHA (8 × 625 mg softgels daily for 60 days)
Number of subjects: 15
Study 29861448 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sunflower oil, 8 × 625 mg softgels daily for 60 days)
Number of subjects: 15
Study 26758884 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium (TIO) 18 µg once daily
Number of subjects: 13
Study 26758884 — intervention group
Group type: EXPERIMENTAL
Intervention: Aclidinium (ACL) 322 µg twice daily
Number of subjects: 13
Study 26758884 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 13
Study 24460863 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (40 mg daily)
Number of subjects: 120
Study 24460863 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 23078181 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS-based mobile epilepsy educational system (MEES) for a 3-month period
Number of subjects: 51
Study 20579648 — intervention group
Group type: EXPERIMENTAL
Intervention: Cap-fitted colonoscopy (CFC)
Number of subjects: 100
Study 20579648 — intervention group
Group type: COMPARATOR
Intervention: Regular colonoscopy
Number of subjects: 100
Study 17999239 — intervention group
Group type: EXPERIMENTAL
Intervention: Length of exposure to a stressor (experimental conditions)
Number of subjects: 127
Study 17999239 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 127
Study 15855902 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-force chiropractic adjustments
Number of subjects: 35
Study 15855902 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 35
Study 11996875 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 32
Study 11996875 — intervention group
Group type: EXPERIMENTAL
Intervention: Left-lateral position
Number of subjects: 32
Study 11996875 — intervention group
Group type: EXPERIMENTAL
Intervention: Right-lateral position
Number of subjects: 32
Study 11996875 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone position
Number of subjects: 32
Study 9431335 — intervention group
Group type: EXPERIMENTAL
Intervention: $5 bill incentive
Number of subjects: 1000
Study 9431335 — intervention group
Group type: COMPARATOR
Intervention: $2 bill incentive
Number of subjects: 1000
Study 8137626 — intervention group
Group type: EXPERIMENTAL
Intervention: LNG-IUD
Number of subjects: 2758
Study 8137626 — intervention group
Group type: COMPARATOR
Intervention: Nova T
Number of subjects: 2758
Study 2505627 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anaesthesia plus sedation
Number of subjects: 19
Study 2505627 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 19
Study 31487749 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodized Stretch Training (PD)
Number of subjects: 16
Study 31487749 — intervention group
Group type: COMPARATOR
Intervention: Non-Periodized Stretch Training (NP)
Number of subjects: 16
Study 28587658 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of SIJ Bone Marrow Edema (BME)
Number of subjects: 185